Advertisement

Screener

Search stocks and ETFs by name or ticker

AAPL VOO Citadel Stock Idea

Advertisement

Aktis Oncology, Inc. (AKTS) SEC Comment Letters

2.8 / 5 stars · 68/120 Roast Me

Prices Financial Statements ›News Ratios Analyst Ratings Insider Transactions SEC Filings Roast Me Breakdown

Annual and Quarterly Reports Proxy and Shareholder Votes Mergers and Tender Offers Listing and Registration SEC Enforcement Actions Late Filing Notices Amended Reports SEC Comment Letters Iran Activity Notices Other Filings

Aktis Oncology, Inc. SEC Comment Letters

No SEC Comment Letters for AKTS on this site yet.

Source checked: its SEC EDGAR filings (CIK 2035832).

Advertisement

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.

About Us·Methodology·Contact Us·Terms·Privacy

Advertisement